Quest Diagnostics Incorporated · NYSE:DGX
Quest Diagnostics — Investor Day (November 2014)
11 slides from Quest Diagnostics's investor day presentation, Nov 5, 2014
Slide 1: Reinventing the Lab Test
Reinventing the Lab Test Jay Wohlgemuth, M.D. Senior Vice President, Medical, Science and Innovation November 5th, 2014
Slide 2: Safe Harbor Disclosure
| 2 Safe Harbor Disclosure The statements in this presentation which are not historical facts may be forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made and which reflect management’s current
Slide 3: Entering The Era of Precision Medicine
| 3 Entering The Era of Precision Medicine DELIVERING EFFECTIVE CARE TO THE RIGHT POPULATIONS AND INDIVIDUALS THROUGH COMPREHENSIVE SOLUTIONS PRECISION MEDICINE IS A RAPIDLY GROWING MULTI-BILLION DOLLAR MARKET TODAY WITH ACCELERATION IN ADOPTION AND NEW APPLICATIONS
Slide 4: Quest is Uniquely Positioned to Lead in Precision Medicine
| 4 Quest is Uniquely Positioned to Lead in Precision Medicine INSIGHTS DISEASE BASED CLINICAL FOCUS Precision Medicine with Actionable Insights Advanced Technologies Big Data Collaborations Comprehensive Solutions
Slide 5: Patient Continuum of Care: Clinical Focus on a Specific Disease State
| 5 Patient Continuum of Care Clinical Franchise Cardiovascular Advanced Lipid Fractions Comprehensive Solutions – Evidence Based Medicine PRIMARY CARE ROUTINE SPECIALIST ESOTERIC Lipid Panel Dementia HCV Genetics & Biomarkers Memory Loss Diagnostics Viral Genomic Testing Screening CLINICAL FOCUS It
Slide 6: Advanced Technology is Enabling Solutions to Key Clinical Problems
| 6 Advanced Sequencing and Molecular Miniaturization and Sample Innovations Bioinformatics and IT Mass Spectrometry and Proteomics ADVANCED TECH Advanced Technology is Enabling Solutions to Key Clinical Problems
Slide 7: We are Using Our Big Data to Help Manage Populations
| 7 >20B test results BIG DATA We are Using Our Big Data to Help Manage Populations and Target Health Care Solutions PUBLISHED IN PRESTIGIOUS PEER REVIEWED JOURNALS
Slide 8: We are Working with World Class Healthcare Leaders
| 8 We are Working with World Class Healthcare Leaders to Make Precision Medicine a Reality PARTNERS
Slide 9: Delivering Comprehensive Solutions
| 9 Delivering Comprehensive Solutions COMPREHENSIVE SOLUTIONS
Slide 10: Case Study: Developing a Comprehensive HCV Solution
| 10 Advanced Technologies Big Data Collaborations Case Study: Developing a Comprehensive HCV Solution to Help Manage a Significant Public Health Threat INSIGHTS Hepatitis C screening guidelines for >78M in US and availability of highly efficacious therapies Rapid adoption and growth of HCV care dia
Slide 11: Key Takeaways
| 11 Key Takeaways Data-driven insights making precision medicine a reality Applying advanced technology for more precise, comprehensive and useful information “Big Data” analytics target effective solutions to the right populations Partnering with world-class thought leaders Moving from selling “a